Loading...
XJPX
4928
Market cap957mUSD
Jul 10, Last price  
4,530.00JPY
1D
0.00%
1Q
1.80%
Jan 2017
23.77%
IPO
378.35%
Name

Noevir Holdings Co Ltd

Chart & Performance

D1W1MN
XJPX:4928 chart
P/E
19.27
P/S
2.39
EPS
235.10
Div Yield, %
5.08%
Shrs. gr., 5y
Rev. gr., 5y
4.54%
Revenues
64.72b
+1.41%
58,669,000,00055,227,000,00052,580,000,00024,581,835,00047,220,289,00046,516,576,00048,253,946,00049,387,000,00051,180,000,00054,473,000,00057,828,000,00059,252,000,00051,841,000,00051,272,000,00061,143,000,00062,552,000,00063,823,000,00064,724,000,000
Net income
8.03b
+0.75%
2,937,000,0002,152,000,0001,565,000,00002,787,693,0004,580,870,0004,349,272,0004,890,000,0005,049,000,0007,077,000,0007,842,000,0007,226,000,0005,618,000,0006,383,000,0007,589,000,0007,673,000,0007,970,000,0008,030,000,000
CFO
7.93b
-13.10%
6,985,000,0005,972,000,0004,595,000,0002,826,942,0004,228,154,9995,778,884,0005,406,854,0004,823,000,0005,959,000,0008,136,000,0004,965,000,00010,191,000,0007,312,000,0009,063,000,0005,845,000,0007,624,000,0009,123,000,0007,928,000,000
Dividend
Sep 30, 2026230 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Noevir Holdings Co., Ltd. is a diversified Japanese conglomerate involved in the creation, production, and distribution of cosmetics, pharmaceuticals, and health food items. Its operations span a wide international footprint, including key markets such as Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, Canada, and Russia. The company's Cosmetics division focuses on developing and manufacturing skincare lines, featuring popular brands like Noevir and Nameraka Honpo. It also offers NOV hypoallergenic products and provides contract manufacturing services for cosmetic and quasi-drug formulations. Within its Pharmaceutical & Health Food segment, Noevir produces items such as Nanten Nodo Ame cough drops and functional beverages like Min Min Da Ha. This division also supplies a range of over-the-counter medications, including cold remedies, eye drops, and digestive aids, alongside various nutritional supplements. The "Other" segment broadens the company's scope through the sale and leasing of apparel and aircraft. Furthermore, the company is involved in manufacturing and selling toiletries, procuring and distributing makeup products and containers, and conducting market research. Its extensive aviation services encompass air transport, charter flight operations, ground handling, hanger rentals, and aircraft flight training, in addition to undertaking other aviation-related tasks. Noevir distributes its diverse product portfolio through multiple channels, including pharmacies, specialized retail outlets, general merchandise stores, supermarkets, e-commerce platforms, convenience stores, and a network of approximately 2,000 Noevir beauty studios and proprietary retail locations. Established in Tokyo, Japan, in 1964, Noevir Holdings Co., Ltd. maintains its headquarters there.
IPO date
Mar 22, 2011
Employees
1,398
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑092024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT